Alcohol News and Research

RSS

TV alcohol advertising ‘watershed’ called for in the UK

Protestors in Britain have called for a ‘watershed’ for alcohol advertising on TV amid claims that millions of children watched the ads during live World Cup games. Alcohol Concern UK says that children as young as four watched alcohol ads from brands such as Stella Artois, Magners, Fosters, Carling and WKD during the World Cup.

18 Oct 2010

Crackdown on liquor licensing breaches needed: Doctors

AMA Victoria has urged the State to look deeper into liquor licensing breaches and has alleged that there have been only four prosecutions out of the near 15,200 breaches. There were 1,200 venues who were reportedly supplying liquor “other than in accordance with the license”. AMA Victoria has asked the state government to introduce harsher penalties for venue operators that breach their liquor licensing conditions.

18 Oct 2010

Studies explore impact of upper GI conditions on sleep

The impact of upper GI conditions, like gastroesophageal reflux disease (GERD) and functional dyspepsia, on sleep—and treatments aimed at providing relief to heartburn/acid reflux patients who suffer from disordered sleep—were explored in three new studies related to sleep dysfunction presented today at the American College of Gastroenterology's (ACG) 75th Annual Scientific meeting in San Antonio, Texas.

18 Oct 2010

Study distinguishes 4 groups of pathological gamblers

Disorganised and emotionally unstable, poorly adapted, suffering from alcohol problems, impulsive, or with a "globally adapted" personality. These are the features of the four diagnosed types of compulsive gamblers identified by researchers at the University Hospital of Bellvitge (IDIBELL) and the Autonomous University of Barcelona (UAB). According to the scientific team, only one of these four shows signs of a significant pathology.

18 Oct 2010

Major advance in treatment of brain disorders with external genes

In the October 17 issue of Nature Methods, researchers at Thomas Jefferson University describe how they can transfer genes into brain neurons intravenously, using a viral gene delivery vehicle (vector) that causes no side effects.

18 Oct 2010

Heavy drinking during pregnancy associated with serious developmental defects in fetus

Scientific data continue to indicate that higher intake of alcohol during pregnancy adversely affects the fetus, and could lead to very severe developmental or other problems in the child. However, most recent publications show little or no effects of occasional or light drinking by the mother during pregnancy.

15 Oct 2010

LifeBridge Health reveals two ways to prevent seasonal flu

You're having that dreaded feeling. Your muscles are aching, you've got a a fever and sore throat . Get ready: It is flu season again! The flu is a respiratory virus that's contagious. In addition to the symptoms above, a, cough and headache, as well as diarrhea may indicate the virus is present.

15 Oct 2010

Omeros receives additional NIDA grant for clinical studies in Addiction program

Omeros Corporation today announced that the National Institute on Drug Abuse (NIDA) has provided an additional grant to fund clinical studies for the Company's Addiction program. This grant, which is for a total of approximately $3.6 million to be paid over a four-year period in equal amounts, will fund direct and indirect costs of Phase 2 clinical studies to be conducted by researchers at the New York State Psychiatric Institute.

14 Oct 2010

$1.5 million DOD award allows U-M scientists to pursue new application for nanoemulsion technology

The U.S. Department of Defense has awarded $1.5 million over three years to the Michigan Nanotechnology Institute for Medicine and Biological Sciences and to Ann Arbor-based NanoBio Corporation to develop and test nanoemulsions with potential to fight a wide range of wound infections, including drug-resistant forms.

13 Oct 2010

The Partnership at Drugfree.org issues statement on FDA approval of VIVITROL for opioid dependence

The U.S. Food and Drug Administration's approval of Alkermes' opioid dependence medication (VIVITROL) for the prevention of relapse to opioid dependence following opioid detoxification is positive news for families of young adults and all those who are struggling to overcome opioid addiction. Addiction, a disease of the human brain, is a chronic illness while opioid dependence is frequently characterized by relapse.

13 Oct 2010

Commercial genetic profiling services should provide detailed information about test results: Report

Direct-to-consumer personal genetic profiling services that claim to predict people's health risks by analysing their DNA are often inconclusive and companies that sell them should provide better information about the evidence on which the results are based, says the UK Nuffield Council on Bioethics, in a new report on the ethics of so-called personalised healthcare services.

13 Oct 2010

SAMHSA awards State Incentive Grants for substance abuse prevention

The Substance Abuse and Mental Health Services Administration (SAMHSA) announced it is awarding up to $53.4 million in new State Incentive Grants for up to five years. These grants are used by states or tribes to implement a strategic approach in communities across the state for substance abuse prevention.

13 Oct 2010

Alkermes' VIVITROL medication for treatment of opioid dependence

Alkermes, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved VIVITROL(naltrexone for extended-release injectable suspension) for the prevention of relapse to opioid dependence, following opioid detoxification.

13 Oct 2010

FDA approves Vivitrol for treatment of opioid-dependent patients

The U.S. Food and Drug Administration today approved Vivitrol to treat and prevent relapse after patients with opioid dependence have undergone detoxification treatment.

13 Oct 2010

Mobile outreach program by sex workers provides key link to health, support services

A mobile outreach program staffed by current and former sex workers is associated with increased entry to detoxification and residential drug treatment among women in street-based sex work, according to an evaluation led by the BC Centre for Excellence in HIV/AIDS (BC-CfE) and the University of British Columbia (UBC).

12 Oct 2010

Engaging in healthy lifestyle can help women with family history control breast cancer risk

Having a family history of breast cancer can lead some women to wonder if the risk is out of their control. However, a study of more than 85,000 postmenopausal women, published in BioMed Central's open access journal Breast Cancer Research, observed that regular physical activity, maintaining a healthy weight, and drinking less alcohol lowers breast cancer risk for those with and without a family history of the disease.

12 Oct 2010

Healthy lifestyle can reduce breast cancer risk in women with family history

Having a family history of breast cancer can lead some people to wonder if their risk is out of their control. However, a study of more than 85,000 postmenopausal women observed that regular physical activity, maintaining a healthy weight, and drinking less alcohol lowers breast cancer risk for women with, and without a family history of the disease.

12 Oct 2010

TruTouch secures grant to accelerate development of next-generation technology platform

TruTouch Technologies, a pioneer in non-invasive biometric intoxication detection systems, today announced that it has secured a $438,000 grant to accelerate the development of its next-generation technology platform.

11 Oct 2010

Philadelphia paramedics plan to sue over health coverage; healthcare merger seeks to lower costs in wash

The city's paramedics are planning to sue over Mayor Nutter's efforts to keep them out of the firefighters union. The dispute goes back to a ruling by the Pennsylvania Labor Relations Board last month that gave the city the right to shift paramedics out of the firefighters union.

11 Oct 2010

BARDA awards $4.2 million contract to Menssana Research to develop breath test for radiation exposure

The Biomedical Advanced Research and Development Authority in the US Department of Health and Human Services has awarded Menssana Research Inc., a company with research facilities in the NJIT Enterprise Development Center, a contract for $4.2 million to develop a breath test for radiation exposure. If the contract is exercised with options, it could total $22.84 million.

11 Oct 2010

Alcohol News and Research

TV alcohol advertising ‘watershed’ called for in the UK

Crackdown on liquor licensing breaches needed: Doctors

Studies explore impact of upper GI conditions on sleep

Study distinguishes 4 groups of pathological gamblers

Major advance in treatment of brain disorders with external genes

Heavy drinking during pregnancy associated with serious developmental defects in fetus

LifeBridge Health reveals two ways to prevent seasonal flu

Omeros receives additional NIDA grant for clinical studies in Addiction program

$1.5 million DOD award allows U-M scientists to pursue new application for nanoemulsion technology

The Partnership at Drugfree.org issues statement on FDA approval of VIVITROL for opioid dependence

Commercial genetic profiling services should provide detailed information about test results: Report

SAMHSA awards State Incentive Grants for substance abuse prevention

Alkermes' VIVITROL medication for treatment of opioid dependence

FDA approves Vivitrol for treatment of opioid-dependent patients

Mobile outreach program by sex workers provides key link to health, support services

Engaging in healthy lifestyle can help women with family history control breast cancer risk

Healthy lifestyle can reduce breast cancer risk in women with family history

TruTouch secures grant to accelerate development of next-generation technology platform

Philadelphia paramedics plan to sue over health coverage; healthcare merger seeks to lower costs in wash

BARDA awards $4.2 million contract to Menssana Research to develop breath test for radiation exposure

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News